Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

War in Ukraine: Impacts on the Polish cancer care system and vaccination challenges

Prof Piotr Rutkowski - National Research Institute of Oncology, Warsaw, Poland
War in Ukraine: Impacts on the Polish cancer care system and vaccination challenges ( Prof Piotr Rutkowski - National Research Institute of Oncology, Warsaw, Poland )
4 May 2022

War in Ukraine: Current and future impacts on the Romanian cancer care system

Dr Nicoleta Antone - The Institute of Oncology, Cluj-Napoca, Romania
War in Ukraine: Current and future impacts on the Romanian cancer care system ( Dr Nicoleta Antone - The Institute of Oncology, Cluj-Napoca, Romania )
29 Apr 2022

Lymphoma Coalition: Challenges for Ukrainian haematological cancer patients

Prof Natacha Bolaños - Lymphoma Coalition, Madrid, Spain
Lymphoma Coalition: Challenges for Ukrainian haematological cancer patients ( Prof Natacha Bolaños - Lymphoma Coalition, Madrid, Spain )
28 Apr 2022

Recurrent non-invasive breast tumours may not always be related to the primary lesion

Dr Tanjina Kader - University of Melbourne, Melbourne, Australia
Recurrent non-invasive breast tumours may not always be related to the primary lesion ( Dr Tanjina Kader - University of Melbourne, Melbourne, Australia )
19 Apr 2022

Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid tumours

Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia
Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid tumours ( Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia )
14 Apr 2022

The adverse events atlas, towards a strategy to predict synergistic adverse events of combination therapies

Prof Bart Westerman - Amsterdam UMC, Amsterdam, Netherlands
The adverse events atlas, towards a strategy to predict synergistic adverse events of combination therapies ( Prof Bart Westerman - Amsterdam UMC, Amsterdam, Netherlands )
13 Apr 2022

FAP-targeted molecular radiotherapy in cancer patients

Prof Jérémie Calais - UCLA, Los Angeles, USA
FAP-targeted molecular radiotherapy in cancer patients ( Prof Jérémie Calais - UCLA, Los Angeles, USA )
1 Apr 2022

Minimal residual disease in multiple myeloma

Prof Ola Landgren - University of Miami, Miami, USA
Minimal residual disease in multiple myeloma ( Prof Ola Landgren - University of Miami, Miami, USA )
8 Mar 2022

Real-world evidence on PET use in Hodgkin lymphoma: An Argentinian perspective

Dr Marta Zerga - Hospital Alemán , Buenos Aires, Argentina
Real-world evidence on PET use in Hodgkin lymphoma: An Argentinian perspective ( Dr Marta Zerga - Hospital Alemán , Buenos Aires, Argentina )
3 Mar 2022

An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validation in NRG/RTOG 9408

Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA
An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validation in NRG/RTOG 9408 ( Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA )
3 Mar 2022

Evaluating a polygenic hazard score to predict risk of developing metastatic or fatal prostate cancer

Dr Meghana Pagadala - University of California San Diego, San Diego, USA
Evaluating a polygenic hazard score to predict risk of developing metastatic or fatal prostate cancer ( Dr Meghana Pagadala - University of California San Diego, San Diego, USA )
25 Feb 2022

Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL

Dr Juliana Pereira & Dr Steven Horwitz
Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL ( Dr Juliana Pereira & Dr Steven Horwitz )
22 Feb 2022